The Public Prosecution Service is not prosecuting chemical company DuPont for the use of the drug DMAc and the miscarriages and stillbirths that the drug caused according to former employees of the company.

The Public Prosecution Service reports to

de Volkskrant

that there is not enough evidence to proceed to criminal prosecution.

At least 44 female employees think that the miscarriages, stillbirths and other problems were caused by having to work with the drug dimethylacetamide (DMAc) in the past.

DuPont used this agent from 1964 to 2004 at its factory in Dordrecht to make lycra yarn, which was used in stockings and tights.

However, in the 1960s and 1970s, the drug is said to be harmful to unborn children.

The company would have been aware of this.

According to the OM, there is too little evidence to demonstrate that there were too high DMAc concentrations in the factory.

That is why the Public Prosecution Service does not proceed to prosecution.

Another case regarding DMAc is still pending

Apart from this, there is another case concerning the harmful substance.

In addition, the FNV union is conducting a lawsuit on behalf of fifteen alleged victims.

A few years ago, Dupont was also negatively in the news because it used the agent perfluorooctanoic acid (PFOA) in Dordrecht in the past.

Residents of the factory would have been exposed to the possibly carcinogenic agent via the air and therefore have too high a concentration of this drug in their blood, the RIVM stated.

The OM is still investigating the PFOA case.

The factory in question is now no longer part of DuPont, but of the Chemours company, which split off from DuPont in 2015.